These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 23303224

  • 1. Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
    Verburg FA, Sweeney R, Hänscheid H, Dießl S, Israel I, Löhr M, Vince GH, Flentje M, Reiners C, Samnick S.
    Nuklearmedizin; 2013; 52(1):36-42. PubMed ID: 23303224
    [Abstract] [Full Text] [Related]

  • 2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1133-9. PubMed ID: 15990019
    [Abstract] [Full Text] [Related]

  • 3. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I, Brandau W, Farmakis G, Samnick S.
    Appl Radiat Isot; 2008 Apr 15; 66(4):513-22. PubMed ID: 18024046
    [Abstract] [Full Text] [Related]

  • 4. Results from a phase I study of 4-l-[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
    Pichler J, Traub-Weidinger T, Spiegl K, Imamovic L, Braat AJAT, Snijders TJ, Verhoeff JJC, Flamen P, Tauchmanova L, Hayward C, Kluge A.
    Neurooncol Adv; 2024 Apr 15; 6(1):vdae130. PubMed ID: 39211520
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S, Romeike BF, Lehmann T, Israel I, Rübe C, Mautes A, Reiners C, Kirsch CM.
    J Nucl Med; 2009 Dec 15; 50(12):2025-32. PubMed ID: 19910430
    [Abstract] [Full Text] [Related]

  • 6. [The possibilities of fractionated external beam repeat irradiation of relapsed primary brain tumours: the first Hungarian experience].
    Mangel L, Sipos L, Fedorcsák I, Viola A, Julow J, Bajcsay A, Németh G, Fodor J.
    Orv Hetil; 2007 Sep 30; 148(39):1843-9. PubMed ID: 17890172
    [Abstract] [Full Text] [Related]

  • 7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):511-9. PubMed ID: 16168843
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD, Holy R, Pinkawa M, Stoffels G, Kaiser HJ, Galldiks N, Herzog H, Coenen HH, Eble MJ, Langen KJ.
    Radiother Oncol; 2011 May 01; 99(2):218-24. PubMed ID: 21497925
    [Abstract] [Full Text] [Related]

  • 9. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S, Hellwig D, Bader JB, Romeike BF, Moringlane JR, Feiden W, Kirsch CM.
    Nucl Med Commun; 2002 Feb 01; 23(2):121-30. PubMed ID: 11891465
    [Abstract] [Full Text] [Related]

  • 10. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS, Woo SY, Teh BS, Prado C, Mai WY, Trask T, Gildenberg PL, Holoye P, Augspurger ME, Carpenter LS, Lu HH, Chiu JK, Grant WH, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):721-6. PubMed ID: 14967426
    [Abstract] [Full Text] [Related]

  • 11. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Koot RW, Habraken JB, Hulshof MC, Paans AM, Bosch DA, Pruim J.
    Acta Neurochir (Wien); 2008 Apr 01; 150(4):345-9. PubMed ID: 18278573
    [Abstract] [Full Text] [Related]

  • 12. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
    Douglas JG, Stelzer KJ, Mankoff DA, Tralins KS, Krohn KA, Muzi M, Silbergeld DL, Rostomily RC, Scharnhorst J, Spence AM.
    Int J Radiat Oncol Biol Phys; 2006 Mar 01; 64(3):886-91. PubMed ID: 16242251
    [Abstract] [Full Text] [Related]

  • 13. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    Pöpperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspötter M, Tonn JC, Tatsch K.
    Eur J Nucl Med Mol Imaging; 2005 Sep 01; 32(9):1018-25. PubMed ID: 15877226
    [Abstract] [Full Text] [Related]

  • 14. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
    Boisserie G, Cornu P, Dormont D, Sahel M, Hardiman C, Tep B, Mandin AM, Barret C, Faillot T, Delattre JY, Monjour A, Poisson M, Marsault C, Philippon J, Simon JM, Baillet F, Mazeron JJ.
    Bull Cancer Radiother; 1996 Sep 01; 83(3):144-52. PubMed ID: 8977564
    [Abstract] [Full Text] [Related]

  • 15. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N, Kolotas C, Birn G, Röddiger S, Filipowicz I, Kontova M, Fountzilas G, Selviaridis P, Baltas D, Heyd R, Anagnostopoulos G, Zamboglou N.
    Strahlenther Onkol; 2007 Oct 01; 183(10):563-70. PubMed ID: 17896088
    [Abstract] [Full Text] [Related]

  • 16. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
    Park SS, Chunta JL, Robertson JM, Martinez AA, Oliver Wong CY, Amin M, Wilson GD, Marples B.
    Int J Radiat Oncol Biol Phys; 2011 Jul 01; 80(3):885-92. PubMed ID: 21489704
    [Abstract] [Full Text] [Related]

  • 17. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomily RC, Hummel S, Scharnhorst J, Krohn KA, Spence AM.
    J Nucl Med; 2002 Dec 01; 43(12):1667-73. PubMed ID: 12468518
    [Abstract] [Full Text] [Related]

  • 18. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
    Arslan M, Karadeniz AN, Aksu G, Güveli M, Fayda M, Doğan AK, Akyüz F.
    J BUON; 2006 Dec 01; 11(1):39-42. PubMed ID: 17318950
    [Abstract] [Full Text] [Related]

  • 19. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
    Reddy K, Gaspar LE, Kavanagh BD, Chen C.
    J Med Imaging Radiat Oncol; 2014 Dec 01; 58(6):714-21. PubMed ID: 24975917
    [Abstract] [Full Text] [Related]

  • 20. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchell L, McNair H, Thomas DG, Robinson S, Johnston DG.
    Clin Endocrinol (Oxf); 2000 Jun 01; 52(6):695-702. PubMed ID: 10848873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.